- Acquired by Undisclosed Investor(s), Mar 2022
About
Novetide is focused on the development and production of peptide-based active pharmaceutical ingredients for the pharmaceutical industry. The company offers a list of commercial products as well as expertise for the development of proprietary peptides. Novetide performs process development, analytical R&D, method validations, and preparations of qualification lots. Its technology platform is based on several proprietary technologies and expertise in the development and production of peptides through sequence assembly, downstream processing, characterization, and documentation of peptide drug substances. Novetide's two FDA-approved production sites have flexible and scalable manufacturing capabilities, with output ranging from grams to tons. Its peptides are currently sold to multinational pharmaceutical companies, start-up companies, and researchers worldwide.
Headcount over time
Q&A
- What is Novetide's primary business?
- Novetide specializes in peptide development and manufacture, producing commercially available peptide products and maintaining a pipeline of products in development.
- When was Novetide founded?
- Novetide was founded in January 1999.
- How many employees does Novetide have?
- Novetide has an employee count in the 11-50 range.
- What is Novetide's primary sector?
- Novetide's primary sector is Health Tech & Life Sciences.
- Does Novetide have FDA-approved production sites?
- Yes, Novetide operates two FDA-approved production sites with flexible and scalable manufacturing capabilities.
- Who are Novetide's target customers?
- Novetide's target customers include multinational pharmaceutical companies, start-up companies, and researchers worldwide.
- What is Teva Pharmaceuticals' relationship with Novetide?
- Teva Pharmaceuticals has held 50% ownership of Novetide since 2000.
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | novetide.com |
|---|---|
| linkedin.com/company/1228122 |
Identifiers & details
| Legal name | Novetide Ltd. |
|---|---|
| Founded | 1999-1 |
| Employees (exact) | 33 |
| Status reason | Acquired (Inactive) by Undisclosed Investor(s) on Mar 2022 - ceased to operate |
Acquisitions & public offerings
Acquired by Undisclosed Investor(s) 2022-03
Radar intelligence
Patents
| EPO | 11 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 512853367 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 1999-11-11 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 2 — people (1), annual_report (1) |
| Registered address | דבורה הנביאה 124 תל אביב - יפו |
Recent registry events
| Date | Event |
|---|---|
| 2026-03-22 | עדכון דירקטורים-הסרת דירקטור |
| 2026-07-09 | דו~ח שנתי |